Non-Hodgkin lymphoma risk might be affected by diet

07-10-2006

"Incidence of NHL has been rising worldwide, but the reasons are undefined. Dietary habits may play a role in the etiology of NHL by influencing the metabolic pathways of several cells of the immune system," investigators in Italy reported.

"This case-control study investigated the relation between food consumption and NHL risk. Between 1999 and 2002, we conducted a hospital-based case-control study on NHL in 2 areas of Italy. Cases were 190 patients (median age 58 years) with incident NHL admitted to specialized and general hospitals. Controls were 484 patients (median age 63 years) with acute non-neoplastic conditions admitted to the same hospitals network of cases," explained R. Talamini and colleagues, Centro di Riferimento Oncologico.

"A validated food-frequency questionnaire was used to assess habitual diet 2 years before interview. Unconditional multiple logistic regression was used to estimate the odds ratios (OR) and the corresponding 95% confidence intervals (CI), with allowance for energy intake, according to the residual model. Consumption of highest versus lowest quartile of pasta/rice (OR=1.87,95% CI: 1.04-3.36) and cheese (OR=1.66, 95% CI: 0.98-2.83) were associated with a significantly increased NHL risk.

"Inverse association was found for vegetables (OR=0.49, 95% CI: 0.28-0.87), fruits (OR=0.51, 95% CI: 0.304.85), and egg consumption (OR=0.59, 95% CI: 0.36-0.97). The association of pasta/rice was also supported by an increased risk of high glycemic load levels (OR=1.86, 95% CI: 1.04-3.32)," announced the scientists.

The researchers concluded, "Our results suggested that diet could affect NHL risk."

Talamini and colleagues published their study in International Journal of Cancer (Food groups and risk of non-Hodgkin lymphoma: A multicenter, case-control study in Italy. Int J Cancer, 2006;118(11):2871-2876).

For additional information, contact R. Talamini, Centro di Riferimento Oncologico, Unita Epidemiology & Biostatistics, Via Pedemontana Occ 12, I-33081 Aviano, Pordenone, Italy.

The publisher of the International Journal of Cancer can be contacted at: Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.

Keywords: Pordenone, Italy, Case Control Study, Diet, Nutrition, Epidemiology, Glycemic Load, Metabolism, Non Hodgkin Lymphoma, Oncology, Cancer Risk Factors, Food Groups.

This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2006, Clinical Oncology Week via NewsRx.com.



Related Diseases: Non-Hodgkin Lymphoma (NHL)
Related Glossary Terms: NHL
 
RECENT NEWS
 
Acute Lymphocytic Leukemia (ALL)
Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes
Silencing a protein could kill T-Cells, reverse leukemia
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
Acute Myeloid Leukemia (AML)
Washington University scientists first to sequence genome of AML patient
Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes
Gemin X Pan Bcl-2 Inhibitor Obatoclax Demonstrates Biological and Clinical Activity in Heavily Pre-Treated Patients with Advanced Chronic Lymphocytic Leukemia
Silencing a protein could kill T-Cells, reverse leukemia
EpiCept Receives Ceplene(R) Marketing Approval in Europe
Amyloidosis
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
STEM CELL TRANSPLANTATION PROCEDURE RESULTS IN LONG-TERM SURVIVAL FOR AMYLOIDOSIS PATIENTS
Neurochem receives approvable letter for eprodisate (KIACTA) for treatment of AA amyloidosis
Neurochem, Inc. (NRMX) Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data
Aplastic Anemia
Blood Stem Cells Originate in the Placenta
Stem Cells from a Person's Own Umbilical Cord Effective Treatment For Life-Threatening Blood Disease, Study Data Show
Alexion's Soliris Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Decision Fails Patients with Transfusion-Dependent Anemia
Chronic Lymphocytic Leukemia (CLL)
World's Top Cancer Research Body Sponsors Landmark COLD-FX(R) Trial
Mayo Clinic Researchers Find Predictive Tests and Early Treatment Delay Progression of Blood Cell Cancer
Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
Gemin X Pan Bcl-2 Inhibitor Obatoclax Demonstrates Biological and Clinical Activity in Heavily Pre-Treated Patients with Advanced Chronic Lymphocytic Leukemia
Silencing a protein could kill T-Cells, reverse leukemia
Chronic Myeloid Leukemia (CML)
Silencing a protein could kill T-Cells, reverse leukemia
A potential new way to make a good anti-leukemia drug even better
2008 SF Leukemia Cup Regatta - Sailing for Leukemia
CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
Improved Survival in Pediatric Leukemia Following Unrelated Bone Marrow but not Peripheral Blood Stem Cell Transplantation
Hodgkin Lymphoma
Hodgkin lymphoma -- new characteristics discovered
Queen's University Using Xceed Molecular's Ziplex in Follicular Lymphoma Study
Lymphoma 101: Everything you need to know
September Is National Leukemia and Lymphoma Awareness Month
Nerve cancer mutations found
Multiple Myeloma
Multiple Myeloma Research Foundation's (MMRF) Annual Gala Raises More Than $1.5 Million to Advance Cancer Research
Thalomid® in Induction Improves Progression-free Survival in Elderly with Myeloma
The IMF says journal editorial documents dramatic increase in survival since the 1980s
FDA Approves Vidaza Label Expansion
Bortezomib (Velcade) in Combo Scores For Initial Myeloma Treatment
Myelodysplastic Syndrome (MDS)
CHMP Awards Positive Opinion for Myelodysplastic Syndrome Drug
Cyclacel expands Phase 2 sapacitabine trial in elderly AML to include patients with MDS
FDA Approves Vidaza Label Expansion
Xanthus Presents Updated Xanafide Phase 2 Data Showing Durable Complete Remissions in Secondary AML
Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine (VNP40101M) in Combination with Cytarabine
Non-Hodgkin Lymphoma (NHL)
Addition of Zevalin(R) to Chemotherapy Effective for Follicular NHL
Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
Queen's University Using Xceed Molecular's Ziplex in Follicular Lymphoma Study
Lymphoma 101: Everything you need to know
Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma
Testicular Cancer
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer
Single Dose of Chemotherapy as Effective as Weeks of Radiation Therapy for Testicular Cancer
Drug avoids radiation for early testicular cancer
Polymorphism Reduces Benefit of Bleomycin in Testicular Cancer
Increased Life Expectancy Seen For Patients With Advanced Colorectal, Ovarian and Testicular Cancer